News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Owens Julia C.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Owens Julia C. (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $4.07, valued at
$67.2k
|
|
| 03/19/2021 |
4
| Owens Julia C. (Executive Chair) has filed a Form 4 on Millendo Therapeutics, Inc.|
Txns:
| Granted 24,000 options to buy
@ $2.29, valued at
$55k
|
|
| 05/27/2020 |
4
| Owens Julia C. (President and CEO) has filed a Form 4 on Millendo Therapeutics, Inc.|
Txns:
| Granted 282,000 options to buy
@ $2, valued at
$564k
|
|
| 02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2019 |
4
| Owens Julia C. (President and CEO) has filed a Form 4 on Millendo Therapeutics, Inc.|
Txns:
| Granted 76,007 options to buy
@ $11.59, valued at
$880.9k
|
|
| 01/17/2019 |
4
| Owens Julia C. (President and CEO) has filed a Form 4 on Millendo Therapeutics, Inc.|
Txns:
| Granted 173,993 options to buy
@ $8.8, valued at
$1.5M
|
|
| 12/11/2018 |
4
| Owens Julia C. (President and CEO) has filed a Form 4 on Millendo Therapeutics, Inc.|
Txns:
| Granted 74,400 shares
@ $0
Granted 60,179 options to buy
@ $1.08, valued at
$65k
Granted 151,600 options to buy
@ $4.44, valued at
$673.1k
Granted 174,839 options to buy
@ $16.4, valued at
$2.9M
|
|
|
|